跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance
Yao Yu Hsieh
, Jia Ling Du,
Pei Ming Yang
血液腫瘤科
衛生福利部雙和醫院
癌症生物學與藥物研發研究所
臺北醫學大學癌症轉譯研究中心
癌症生物學與藥物研發博士學位學程
研究成果
:
雜誌貢獻
›
文章
›
同行評審
3
引文 斯高帕斯(Scopus)
總覽
指紋
指紋
深入研究「Repositioning VU-0365114 as a novel microtubule-destabilizing agent for treating cancer and overcoming drug resistance」主題。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Drug Resistance
100%
Anticarcinogen
50%
Adverse Event
50%
Drug Development
50%
Nude Mouse
50%
Tumor Growth
50%
Multiple Drug Resistance
50%
P-Glycoprotein
50%
Colorectal Tumor
50%
Tubulin
50%
Colorectal Cancer
50%
Muscarinic Receptor
50%
Positive Allosteric Modulator
50%
Repurposing
50%
Neoplasm
50%
Drug Repositioning
50%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
100%
Drug Resistance
100%
Gene Expression
50%
Nude Mouse
50%
Cancer Cell
50%
Anticancer
50%
Tubulin
50%
Multidrug Resistance
50%
Kinome
50%
Muscarinic Acetylcholine Receptor M5
50%
Tumor Progression
50%
P-Glycoprotein
50%
Medicine and Dentistry
Malignant Neoplasm
100%
Microtubule
100%
Drug Resistance
100%
Antineoplastic Activity
40%
In Vitro
20%
Cancer Therapy
20%
Cancer Cell
20%
Gene Expression
20%
Adverse Event
20%
Anticarcinogen
20%
Tumor Progression
20%
ABC Transporter Subfamily B
20%
Tubulin
20%
Colorectal Tumor
20%
Colorectal Cancer
20%
Multidrug Resistance
20%
Tumor Xenograft
20%
Muscarinic Acetylcholine Receptor
20%
Allosteric Modulator
20%
Drug Repositioning
20%